Acceptability and impact of zidovudine for prevention of mother-to- child human immunodeficiency virus-1 transmission in France

Journal of Pediatrics

Volumn 131, Issue 6, 1997, Pages 857-862

  Mayaux, M J ^a   Teglas, J P ^a   Mandelbrot, L ^a   Berrebi, A ^a   Gallais, H ^a   Matheron, S ^a   Ciraru Vigneron, N ^a   Parnet Mathieu, F ^a   Bongain, A ^a   Rouzioux, C ^a   Delfraissy J , F ^a   Blanche, S ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; ZIDOVUDINE;

ARTICLE; FEMALE; FRANCE; HEALTH CARE POLICY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INFECTION PREVENTION; PLACENTAL TRANSFER; PRIORITY JOURNAL; SCREENING TEST; VIRUS TRANSMISSION;

EID: 0031459441     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(97)70033-7     Document Type: Article

References (16)

1. EM Connor RS Sperling R Gelber Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment N Engl J Med 331 1994 1173 1180
2. SA Fiscus AA Adimora VJ Schoenbach Perinatal HIV infection and the effect of zidovudine therapy on transmission in rural and urban countries JAMA 275 1996 1483 1488
3. AA Wiznia M Crane G Lambert J Sansary A Harris L Solomon Zidovudine use to reduce perinatal HIV type I transmission in an urban medical center JAMA 275 1996 1504 1506
4. DV Landers RL Sweet Reducing mother-to-infant transmission of HIV: the door remains open N Engl J Med 334 1996 1664
5. E Couturier Y Brossard C Larsen HIV infection at outcome of pregnancy in the Paris area, France Lancet 340 1992 707 709
6. European Centre for the Epidemiological Monitoring of AIDS HIV/AIDS surveillance in Europe 30 June 1997 Quarterly report no. 54
7. Recommandations of the US Public Health service task force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus MMWR Morbid Mortal Wkly Rep 43 RR-11 1994 1 20
8. Centers for Disease Control and Prevention 1994 Revised classification system for human immunodeficiency virus infection in children less than 13 years of age MMWR Morbid Mortal Wkly Rep RR-12 1994 1 10
9. PJ Boyer M Dillon M Navaie Factors predictive of maternal-fetal transmission of HIV-1: preliminary analysis of zidovudine given during pregnancy and/or delivery JAMA 271 1994 1925 1930
10. PB Matheson EJ Abrams P Thomas Efficacy of antenatal zidovuidne in reducing perinatal transmission of human immunodeficiency virus type 1 J Infect Dis 172 1995 353 358
11. SM Landesman LA Kalish DN Burns Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child N Engl J Med 334 1996 707 709
12. L Mandelbrot MJ Mayaux A Bongain Obstetrical factors and mother to child transmission of HIV-1: the French perinatal cohort studies Am J Obstet Gynecol 175 1996 661 667
13. EM Rodriguez LM Mofenson BH Chang Association of maternal drug use during pregnancy with maternal HIV culture positivity and perinatal HIV transmission in the women and infants study AIDS 10 1996 273 282
14. LM Mofenson A critical review of studies evaluating the relationship of mode of delivery to perinatal transmission of human immunodeficiency virus Pediatr Infect Dis J 14 1995 169 177
15. LM Frenkel LE Wagner LM Demeter Effects of zidovudine use during pregnancy on resistance and vertical transmission of human immunodeficiency virus type 1 Clin Infect Dis 20 1995 1321 1326
16. R Sperling Maternal viral load and the success of zidovudine for the reduction of maternal-infant HIV-1 transmission N Engl J Med 335 1996 1621 1629